NAD+ and Alcohol: What Is Claimed and What Is Shown
The NAD+ hangover drip is one of the more successful products of the wellness era: a mobile nurse, a bag of fluid, and a promise that the coenzyme alcohol depletes will be put back before Monday. Behind it sits a real piece of biochemistry — alcohol genuinely consumes NAD+ — and an inference from that biochemistry that has never been tested in a human trial. This page separates the two.
It is not a page about drinking less, or about alcohol and health after fifty. The executive alcohol page covers what alcohol does to the biomarkers we measure, and the semaglutide and alcohol page covers the one drug on this site with trial evidence of changing how much people drink. This page is only about the NAD+ claim.
The biochemistry that is true
Alcohol is broken down in the liver in two steps, and both consume NAD+. The enzyme that turns ethanol into acetaldehyde takes an NAD+ and returns it as NADH; the enzyme that turns acetaldehyde into acetate does the same. A heavy evening therefore shifts the liver's NAD+/NADH balance hard toward NADH, and that shift is not a side note: it is the reason alcohol disrupts fat metabolism, blood sugar and lactate handling, and part of why the liver of a heavy drinker accumulates fat. Chronic heavy drinking also lowers NAD+ more durably, and animal studies of alcohol-related liver injury show NAD+ depletion as part of the mechanism.
So the premise — alcohol depletes NAD+ — is correct. It is what the marketing does with it that outruns the evidence.
The inference that is untested
The argument runs: alcohol depletes NAD+; a hangover is what depletion feels like; therefore replacing NAD+ relieves the hangover, and, by extension, "detoxes" the body from alcohol. Each step after the first is an assumption.
A hangover is not primarily an NAD+ deficit. Its best-supported causes are dehydration and electrolyte loss, acetaldehyde toxicity, the inflammatory response alcohol provokes, disrupted sleep, low blood sugar, and the congeners in darker drinks. Some of those are downstream of the NAD+/NADH shift; most are not, and the shift itself has largely reversed by the time the hangover peaks, because the liver has finished metabolizing the alcohol.
And no trial has tested NAD+ — by any route — for hangover, for alcohol "detox," or for recovery after drinking. Not a small one, not a poor one. The evidence offered for the drip is testimonial, and the placebo effect for feeling better after an hour lying down with a liter of fluid is considerable on its own. A bag of saline with nothing in it will improve a hangover; that is the part of the drip that works.
What NAD+ has been studied for, in relation to alcohol, is different: a small number of early-stage and animal studies on alcohol-related liver injury, and a research interest in whether NAD+ precursors might reduce craving or protect the liver in people with alcohol use disorder. That work is preliminary, it is about disease rather than hangovers, and it is not a basis for anything we prescribe.
What we will not claim
We prescribe NAD+ injections for the reasons on the main page, with the caveats the main page is candid about. We do not prescribe it for hangovers, and we do not describe it as an alcohol detox, a liver cleanse, or a way to drink with less consequence. There is no evidence for the first, the second and third are not meaningful medical concepts, and the fourth is a message we would not send even if the evidence existed.
We also do not treat alcohol use disorder, and NAD+ is not a treatment for it. A person who is drinking more than they want to and finds themselves searching for a way to undo it has a real problem with real treatments — behavioral, pharmacological, and in some cases with medications on this site prescribed for other reasons — and the right first step is a frank conversation with a clinician, which we will have and refer from. The executive alcohol page sets out what the markers show and where the line is.
If you drink and take NAD+
Two practical notes. NAD+ injected shortly after drinking is more likely to produce nausea and flushing, as the side effects page explains — the two do not mix well on the day. And a person whose reason for wanting NAD+ is fatigue should know that regular alcohol is among the commonest reversible causes of fatigue after forty-five, and that the fatigue workup will ask about it before anything is prescribed. NAD+ does not treat the fatigue alcohol causes; less alcohol does.
Frequently asked questions
There is no trial evidence that it does. Alcohol does consume NAD+ during metabolism, but a hangover is mostly dehydration, acetaldehyde, inflammation and poor sleep, and the NAD+ shift has largely reversed by the time it peaks. The fluid in a hangover drip is the part that helps.
Yes — both steps of alcohol metabolism in the liver consume it. Chronic heavy drinking lowers it more durably. That is real biochemistry; the leap to "so NAD+ cures hangovers" is not.
"Detox" is not a medical concept in this sense. The liver metabolizes alcohol on its own schedule and NAD+ does not speed it. No trial has tested NAD+ for recovery after drinking.
There is early research interest in NAD+ precursors in alcohol use disorder, but nothing that supports prescribing it for that purpose. We do not treat alcohol use disorder; we refer.
Better not the same day — nausea and flushing are more likely. It is not harmful in the way a drug interaction would be; it is simply unpleasant.
For the reasons and with the caveats on the main page — and not for hangovers. We would rather say so than sell a drip.
Where this fits in your plan
The NAD+ Injection page covers what we prescribe it for. If alcohol is part of why you are tired, the fatigue workup comes first, and it will ask.
We measure first. Then we act.
References
- Cederbaum AI. Alcohol metabolism. Clinics in Liver Disease 2012;16:667–685.
- Penning R et al. The pathology of alcohol hangover. Current Drug Abuse Reviews 2010;3:68–75.
- Verster JC et al. Hangover research needs: proceedings of the 5th Alcohol Hangover Research Group meeting. Current Drug Abuse Reviews 2013;6:245–251.
- Assiri MA et al. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. Human Genomics 2019;13:65.
- Radenkovic D, Reason, Verdin E. Clinical evidence for targeting NAD therapeutically. Pharmaceuticals 2020;13:247.
- Back toNAD+ Injection
- NAD+ injection side effectsFlushing, nausea and cramping are the effects people report on NAD+, and they follow how fast it enters the body. What is common with the injection, what belongs to IV drips, and what to stop for.Read
- Alcohol and your biomarkersThe drinking pattern nobody counts, what it moves on a lab panel, and what reverses.Read
- Semaglutide and alcoholPeople on semaglutide often drink less without trying. What the 2025 and 2026 trials found, why it happens, and the practical safety points if you do drink on it.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
If you are concerned about your drinking, the SAMHSA National Helpline is 1-800-662-4357.